Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Insulet Corporation

< Previous 1 2 3 Next >
Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Full Year 2023 Revenue Increase of 30% (30% Constant Currency1) and Fourth Quarter 2023 Revenue Increase of 38% Year-Over-Year (37% Constant Currency)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at The Raymond James & Associates 45th Annual Institutional Investors Conference
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces Changes to Board of Directors with Retirements and New Appointments
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Third Quarter 2023 Revenue Increase of 27% Year-Over-Year (25% Constant Currency1)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Spotlights Diabetes Awareness on World Diabetes Day and Throughout November
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces CFO Transition
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present Extended Real-World Evidence and Best Practices for Optimizing Care with Omnipod® 5
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Third Quarter 2023 Financial Results on November 2, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces Full Market Release of Omnipod® 5 Automated Insulin Delivery System in Germany
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports Second Quarter 2023 Revenue Increase of 32% Year-Over-Year (32% Constant Currency1)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Second Quarter 2023 Financial Results on August 8, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Celebrates One Year of Omnipod® 5 at the American Diabetes Association 83rd Scientific Sessions
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces Omnipod® 5 Automated Insulin Delivery System is Now Available in the United Kingdom
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces New Organizational Structure to Drive Further Growth
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Reports First Quarter 2023 Revenue Increase of 21% Year-Over-Year (23% Constant Currency1)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Publishes 2022 Sustainability Report Focused on Innovating for the Future and Preserving the Environment
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Announces FDA Clearance of Omnipod GO™, a First-of-its-Kind Basal-Only Insulin Pod, Further Simplifying Life for People with Type 2 Diabetes
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce First Quarter 2023 Financial Results on May 4, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
CORRECTING and REPLACING Insulet Reports Full Year 2022 Revenue Increase of 19% (22% constant currency1) and Fourth Quarter 2022 Revenue Increase of 20% Year-Over-Year (24% constant currency)
From Insulet Corporation
Via Business Wire
Tickers PODD
Highly Anticipated Omnipod® 5 Real-World Evidence to be Presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Acquires Assets of Automated Glucose Control LLC (AGC)
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Present at Upcoming Investor Conferences
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet Acquires Insulin Pump Patents from Bigfoot Biomedical as Both Companies Prioritize Improved Insulin Delivery Technologies
From Insulet Corporation
Via Business Wire
Tickers PODD
Insulet to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
From Insulet Corporation
Via Business Wire
Tickers PODD
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS